Showing results (161-170 of 3,162) with videos related to

Sort By:
Pageof 317
Translational Oncology|September 1, 2012
Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancerJonathan A Ewald, David F Jarrard
Translational Oncology|June 29, 2012
A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular ProfilesLaura K Donovan, Nicola E Potter, Tracy Warr, et al.
Translational Oncology|June 29, 2012
Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of GadoliniumGerald P Guntle, Bhumasamudram Jagadish, Eugene A Mash, et al.
Translational Oncology|June 29, 2012
Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary CulturesGregory K Friedman, Marilyn C Haas, Virginia M Kelly, et al.
Translational Oncology|January 26, 2025
CD47 is a tumor cell-derived exosomal signature and regulates tumor immune microenvironment and immunotherapy responsesYifei Luan, Yinghui Zhang, Shangjin Li, et al.
Translational Oncology|January 14, 2025
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinomaBo Li, Meilong Shi, Yang Wang, et al.
Translational Oncology|January 14, 2025
Cross-Talk between NOK and EGFR: Juxtamembrane and Kinase domain interactions enhancing STAT3/5 signaling in breast cancer tumorigenesisYinyin Wang, Bingdong Zhang, Chunhua He, et al.
Translational Oncology|January 15, 2025
Impact of radiotherapy on secondary lung cancer risk and survival in elderly female breast cancer survivorsJieming Lu, Zhimin Shen, Xiaoqing Wang, et al.
Translational Oncology|January 15, 2025
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemiaQi Zhou, Yongyu Guan, Pingping Zhao, et al.
Translational Oncology|January 13, 2025
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapyGaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Pageof 317